4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, <i>in-vitro</i>, and <i>in-silico</i> biological studies-Reference-Cited by-同舟云学术

4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies

Published:2022-03-30 Issue:1 Volume:37 Page:994-1004
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Nada Hossam¹^ORCID,Elkamhawy Ahmed¹²^ORCID,Abdellattif Magda H.³^ORCID,Angeli Andrea⁴^ORCID,Lee Chang Hoon¹,Supuran Claudiu T.⁴^ORCID,Lee Kyeong¹

Affiliation:

1. BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Republic of Korea

2. Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

3. Department of Chemistry, College of Science, Taif University, Taif, Saudi Arabia

4. NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Sesto Fiorentino, Florence, Italy

Funder

National Research Foundation of Korea

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2022.2055553

Reference49 articles.

1. Carbonic anhydrases as targets for medicinal chemistry

2. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

3. Inhibition Profiles of Some Symmetric Sulfamides Derived from Phenethylamines on Human Carbonic Anhydrase I, and II Isoenzymes

4. Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site

5. Human carbonic anhydrases

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting breast cancer with rationally designed quinazolines: A scaffold hopping strategy;Journal of Molecular Structure;2024-11

2. Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors;International Journal of Biological Macromolecules;2024-11

3. Chalcone‐based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studies;Archiv der Pharmazie;2024-09-06

4. A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments;European Journal of Medicinal Chemistry;2024-08

5. Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review;Archiv der Pharmazie;2024-04-29